BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

923 related articles for article (PubMed ID: 31257214)

  • 1. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study.
    Mas-Peiro S; Seppelt PC; Weiler H; Mohr GL; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
    J Invasive Cardiol; 2019 Jul; 31(7):E199-E204. PubMed ID: 31257214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-expanding Portico Valve Versus Balloon-expandable SAPIEN XT Valve in Patients With Small Aortic Annuli: Comparison of Hemodynamic Performance.
    Del Trigo M; Dahou A; Webb JG; Dvir D; Puri R; Abdul-Jawad Altisent O; Campelo-Parada F; Thompson C; Leipsic J; Stub D; DeLarochellière R; Paradis JM; Dumont E; Doyle D; Mohammadi S; Pasian S; Côté M; Pibarot P; Rodés-Cabau J
    Rev Esp Cardiol (Engl Ed); 2016 May; 69(5):501-8. PubMed ID: 26739827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
    Makkar RR; Cheng W; Waksman R; Satler LF; Chakravarty T; Groh M; Abernethy W; Russo MJ; Heimansohn D; Hermiller J; Worthley S; Chehab B; Cunningham M; Matthews R; Ramana RK; Yong G; Ruiz CE; Chen C; Asch FM; Nakamura M; Jilaihawi H; Sharma R; Yoon SH; Pichard AD; Kapadia S; Reardon MJ; Bhatt DL; Fontana GP
    Lancet; 2020 Sep; 396(10252):669-683. PubMed ID: 32593323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thirty-Day Outcomes in 100 Consecutive Patients Undergoing Transfemoral Aortic Valve Replacement With the Portico Valve on an All-Comer Basis.
    Mas-Peiro S; Vasa-Nicotera M; Weiler H; Papadopoulos N; De Rosa R; Zeiher AM; Fichtlscherer S
    J Invasive Cardiol; 2017 Dec; 29(12):431-436. PubMed ID: 29207365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
    Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
    Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights From the BEAT International Collaborative Registrys.
    Mangieri A; Tchetchè D; Kim WK; Pagnesi M; Sinning JM; Landes U; Kornowski R; De Backer O; Nickenig G; Ielasi A; De Biase C; Søndergaard L; De Marco F; Montorfano M; Chiarito M; Regazzoli D; Stefanini G; Presbitero P; Toggweiler S; Tamburino C; Immè S; Tarantini G; Sievert H; Schäfer U; Kempfert J; Wöehrle J; Gallo F; Laricchia A; Latib A; Giannini F; Colombo A
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008714. PubMed ID: 32646304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
    Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.
    Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Zeus T; Pilgrim T; Schofer J; Zweiker D; Testa L; Taramasso M; Hildick-Smith D; Abizaid A; Wolf A; Van Mieghem NM; Sedaghat A; Wöhrle J; Khogali S; Van der Heyden JAS; Webb JG; Estévez-Loureiro R; Mylotte D; MacCarthy P; Brugaletta S; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Veulemans V; Asami M; Windecker S; Eitan A; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Alsanjari O; Siqueira D; Jensen CJ; Naber CK; Ziviello F; Sinning JM; Seeger J; Rottbauer W; Brouwer J; Alenezi A; Wood DA; Tzalamouras V; Regueiro A; Colombo A; Latib A
    JACC Cardiovasc Interv; 2019 Mar; 12(5):433-443. PubMed ID: 30846081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Matched Outcome of Evolut-R vs CoreValve Transcatheter Aortic Valve Implantation.
    Landes U; Bental T; Barsheshet A; Assali A; Vaknin Assa H; Levi A; Orvin K; Kornowski R
    J Invasive Cardiol; 2017 Feb; 29(2):69-74. PubMed ID: 28145874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort.
    Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T
    Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial.
    Abdel-Wahab M; Neumann FJ; Mehilli J; Frerker C; Richardt D; Landt M; Jose J; Toelg R; Kuck KH; Massberg S; Robinson DR; El-Mawardy M; Richardt G;
    J Am Coll Cardiol; 2015 Aug; 66(7):791-800. PubMed ID: 26271061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves.
    Wernly B; Zappe AK; Unbehaun A; Sinning JM; Jung C; Kim WK; Fichtlscherer S; Lichtenauer M; Hoppe UC; Alushi B; Beckhoff F; Wewetzer C; Franz M; Kretzschmar D; Navarese E; Landmesser U; Falk V; Lauten A
    Clin Res Cardiol; 2019 Jan; 108(1):83-92. PubMed ID: 30003366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Hemodynamic Performance of the Balloon-expandable SAPIEN 3 Versus Self-expandable Evolut R Transcatheter Valve: A Case-matched Study.
    Enríquez-Rodríguez E; Amat-Santos IJ; Jiménez-Quevedo P; Martín-Morquecho I; Tirado-Conte G; Pérez-Vizcayno MJ; Gómez de Diego JJ; Arnold R; Aldazábal A; Rojas P; de Agustín A; Del Trigo M; Gutiérrez H; San Román JA; Macaya C; Nombela-Franco L
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):735-742. PubMed ID: 29191782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial.
    Abdel-Wahab M; Landt M; Neumann FJ; Massberg S; Frerker C; Kurz T; Kaur J; Toelg R; Sachse S; Jochheim D; Schäfer U; El-Mawardy M; Robinson DR; Richardt G;
    JACC Cardiovasc Interv; 2020 May; 13(9):1071-1082. PubMed ID: 32305398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.
    Linke A; Holzhey D; Möllmann H; Manoharan G; Schäfer U; Frerker C; Worthley SG; van Boven AJ; Redwood S; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Walther T
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e005206. PubMed ID: 29444998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of three different new generation transcatheter aortic valve prostheses.
    Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.